“Magic” for Those Who Can’t Take Pills: Groundbreaking HIV Treatment Achieves 98% Viral Suppression
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
University of California, San Francisco5d
Injectable Therapy Is ‘Magic’ for Those Who Can’t Take HIV Pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...
Hosted on MSN9d
Long-acting injectable HIV therapy offers hope for those unable to take pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments ... the UCSF HIV/AIDS clinic ...
Medindia6d
"Magic Shot" Vs. Daily Pills: Is This the Future of HIV Treatment?
A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who find it challenging to adhere to daily pill regimens. This ...
Clinical Trials Arena on MSN3d
Gilead to launch Phase III once-yearly HIV PrEP trial after Phase I success
Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...
This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
EurekAlert!10d
Injectable Therapy is 'magic' for those who can’t take HIV pills
Patients who struggle to take daily HIV pills can benefit from long-acting ... the UCSF HIV/AIDS clinic at Zuckerberg San Francisco General Hospital. They studied data from 370 patients ...